Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01630083What this trial is testingEfficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerWho this might be right forCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma Astellas Pharma Global Development, Inc. 252
Testing effectiveness (Phase 2)Ended earlyNCT00177255What this trial is testingDocetaxel in Combination With Capecitabine in Stomach and Esophagus CancersWho this might be right forCancer University of Pittsburgh 40
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Testing effectiveness (Phase 2)Study completedNCT00006081What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer M.D. Anderson Cancer Center 37
Not applicableLooking for participantsNCT07675967What this trial is testingClonal Hematopoiesis Chemotherapy and Radiation Effects StudyWho this might be right forLung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more Dana-Farber Cancer Institute 5,000
Large-scale testing (Phase 3)UnknownNCT04385550What this trial is testingAnlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction AdenocarcinomaWho this might be right forAdvanced Gastric and Gastro-oesophageal Junction Adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 528
Early research (Phase 1)Study completedNCT01561014What this trial is testingOxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more Wake Forest University Health Sciences 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04704934What this trial is testingTrastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)Who this might be right forGastric Cancer, AdenocarcinomaGastroesophageal Junction Adenocarcinoma Daiichi Sankyo 490
Testing effectiveness (Phase 2)UnknownNCT03139487What this trial is testingPhase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismWho this might be right forCancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more Asan Medical Center 176
Testing effectiveness (Phase 2)Study completedNCT05007106What this trial is testingMK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)Who this might be right forUterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more Merck Sharp & Dohme LLC 613
Not applicableLooking for participantsNCT04907643What this trial is testingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesWho this might be right forCancer PainVisceral PainGastrointestinal Neoplasms+76 more Cedars-Sinai Medical Center 360
Early research (Phase 1)Study completedNCT04772989What this trial is testingEvaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more Arcus Biosciences, Inc. 94
Early research (Phase 1)Study completedNCT00005638What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT04221893What this trial is testingRadiation Therapy for the Treatment of Metastatic Gastrointestinal CancersWho this might be right forStage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more University of California, San Francisco 28
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Active Not RecruitingNCT02678182What this trial is testingPlanning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialWho this might be right forAdenocarcinoma of the OesophagusAdenocarcinoma of the Gastro-oesophageal JunctionAdenocarcinoma of the Stomach Royal Marsden NHS Foundation Trust 494
Large-scale testing (Phase 3)Active Not RecruitingNCT03504397What this trial is testingCompare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.Who this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Study completedNCT03409848What this trial is testingIpilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric AdenocarcinomaWho this might be right forGastric CancerEsophageal CancerAdenocarcinoma Gastric+3 more AIO-Studien-gGmbH 97
Testing effectiveness (Phase 2)Study completedNCT02096666What this trial is testingA Phase 1/2 Study Evaluating AMG 337 in Asian SubjectsWho this might be right forStomach Neoplasms Amgen 11